United Kingdom · Report · Written statement
UIN HLWS620
Strengthened Regulatory Position on Sodium Valproate
Introduced
24 April 2018
Last action
24 April 2018 · Written statement
Status
Lords
Sponsors
—
Subjects
Discovery layer
Source updated
24 April 2018
Summary
The EU review into the safety of sodium valproate has now been completed and has recommended that a contraindication for valproate should be introduced in pregnancy and in girls and women of child bearing potential unless they enrolled in a Pregnancy Prev...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 April 2018
Written statement
The EU review into the safety of sodium valproate has now been completed and has recommended that a contraindication for valproate should be introduced in pregnancy and in girls and women of child bearing potential unless they enrolled in a Pregnancy Prev...
Source: Lords
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2018-04-24/HLWS620
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/890162
- uk · ws-890162 · source updated 24 April 2018